Viewing Study NCT00086892


Ignite Creation Date: 2025-12-24 @ 3:14 PM
Ignite Modification Date: 2026-02-20 @ 5:56 PM
Study NCT ID: NCT00086892
Status: COMPLETED
Last Update Posted: 2014-02-14
First Post: 2004-07-08
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Sponsor: Gynecologic Oncology Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module References Module